跳到正文
原文
Regulatory Affairs Professionals Society· @RAPSorg · X·· 4 小时前AI 评分22
AI 导读

过去15年间,FDA批准的小分子药物相关专利数量有所上升,其中大部分增长与非主专利的使用有关。 https://hubs.la/Q04zT_Gx0

正文

Over the last 15 years, there has been an uptick in the number of patents associated with small-molecule drugs approved by FDA, with a majority of the increase linked to the use of non-primary patents.

https://hubs.la/Q04zT_Gx0

来源:Regulatory Affairs Professionals Society · x.com